Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Device center regulates 'tools of the trade'.

JAMA

Simmons K.
PMID: 3900451
JAMA. 1985 Oct 25;254(16):2243-4.

No abstract available.

Cite
Simmons K. Device center regulates 'tools of the trade'. JAMA. 1985;254(16):2243-4
Simmons, K. (1985). Device center regulates 'tools of the trade'. JAMA, 254(16), 2243-4.
Simmons, K. "Device center regulates 'tools of the trade'." JAMA vol. 254,16 (1985): 2243-4.
Simmons K. Device center regulates 'tools of the trade'. JAMA. 1985 Oct 25;254(16):2243-4. PMID: 3900451.
Copy Download .nbib Format: NLM
Improving the uptake of medical device training to promote patient safety.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Shields R, Latter K.
PMID: 31736285
Nurs Stand. 2019 Aug 31;35(1):31-34. doi: 10.7748/ns.2019.e11219. Epub 2019 May 30.

Safe and effective patient care is dependent on the appropriate use of medical devices, so it is necessary to ensure that all nursing staff are competent in their use. This article describes how one urology ward in a large...

Cite
Shields R, Latter K. Improving the uptake of medical device training to promote patient safety. Nurs Stand. 2019;35(1):31-34doi: 10.7748/ns.2019.e11219.
Shields, R., & Latter, K. (2019). Improving the uptake of medical device training to promote patient safety. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 35(1), 31-34. https://doi.org/10.7748/ns.2019.e11219
Shields, Rachel, and Latter, Karine. "Improving the uptake of medical device training to promote patient safety." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 35,1 (2019): 31-34. doi: https://doi.org/10.7748/ns.2019.e11219
Shields R, Latter K. Improving the uptake of medical device training to promote patient safety. Nurs Stand. 2019 Aug 31;35(1):31-34. doi: 10.7748/ns.2019.e11219. Epub 2019 May 30. PMID: 31736285.
Copy Download .nbib Format: NLM
From BSE to MDT, scientific opinion and public policy on risks in medical devices.

Medical device technology

Williams D.
PMID: 10344883
Med Device Technol. 1998 Nov;9(9):6-8, 10-1.

Risk management is not always straightforward, especially if it has to be based on inadequate data. When the arguments are fuelled by fears for public health, politicians are forced to take difficult decisions and all too frequently it is...

Cite
Williams D. From BSE to MDT, scientific opinion and public policy on risks in medical devices. Med Device Technol. 1998;9(9):6-8, 10-1
Williams, D. (1998). From BSE to MDT, scientific opinion and public policy on risks in medical devices. Medical device technology, 9(9), 6-8, 10-1.
Williams, D. "From BSE to MDT, scientific opinion and public policy on risks in medical devices." Medical device technology vol. 9,9 (1998): 6-8, 10-1.
Williams D. From BSE to MDT, scientific opinion and public policy on risks in medical devices. Med Device Technol. 1998 Nov;9(9):6-8, 10-1. PMID: 10344883.
Copy Download .nbib Format: NLM
Complication Versus Consequence: Defining Device-Related Outcomes in Children With Medical Complexity.

Hospital pediatrics

Russell CJ.
PMID: 30530804
Hosp Pediatr. 2019 Jan;9(1):70-71. doi: 10.1542/hpeds.2018-0230. Epub 2018 Dec 10.

No abstract available.

Cite
Russell CJ. Complication Versus Consequence: Defining Device-Related Outcomes in Children With Medical Complexity. Hosp Pediatr. 2018;9(1):70-71doi: 10.1542/hpeds.2018-0230.
Russell, C. J. (2019). Complication Versus Consequence: Defining Device-Related Outcomes in Children With Medical Complexity. Hospital pediatrics, 9(1), 70-71. https://doi.org/10.1542/hpeds.2018-0230
Russell, Christopher J. "Complication Versus Consequence: Defining Device-Related Outcomes in Children With Medical Complexity." Hospital pediatrics vol. 9,1 (2019): 70-71. doi: https://doi.org/10.1542/hpeds.2018-0230
Russell CJ. Complication Versus Consequence: Defining Device-Related Outcomes in Children With Medical Complexity. Hosp Pediatr. 2019 Jan;9(1):70-71. doi: 10.1542/hpeds.2018-0230. Epub 2018 Dec 10. PMID: 30530804.
Copy Download .nbib Format: NLM
Approval-adjusted recall rates of high-risk medical devices from 2002-2016 across food and drug administration device categories.

Issues in law & medicine

Ghobadi CW, Janetos TM, Tsai S, Welty L, Walter JR, Xu S.
PMID: 31179672
Issues Law Med. 2019;34(1):77-92.

Between 2002 and 2016, 806 million medical devices were recalled. When approving a device, the FDA employs advisory boards organized by medical specialty (e.g. cardiovascular) to make approval recommendations. Previous work has demonstrated high numbers of recalled orthopedic and...

Cite
Ghobadi CW, Janetos TM, Tsai S, et al. Approval-adjusted recall rates of high-risk medical devices from 2002-2016 across food and drug administration device categories. Issues Law Med. 2019;34(1):77-92
Ghobadi, C. W., Janetos, T. M., Tsai, S., Welty, L., Walter, J. R., & Xu, S. (2019). Approval-adjusted recall rates of high-risk medical devices from 2002-2016 across food and drug administration device categories. Issues in law & medicine, 34(1), 77-92.
Ghobadi, Comeron W, et al. "Approval-adjusted recall rates of high-risk medical devices from 2002-2016 across food and drug administration device categories." Issues in law & medicine vol. 34,1 (2019): 77-92.
Ghobadi CW, Janetos TM, Tsai S, Welty L, Walter JR, Xu S. Approval-adjusted recall rates of high-risk medical devices from 2002-2016 across food and drug administration device categories. Issues Law Med. 2019;34(1):77-92. PMID: 31179672.
Copy Download .nbib Format: NLM
Materiovigilance: Concept, Structure and Emerging Perspective for Patient's Safety in India.

Drug research

Hoda F, Verma R, Arshad M, Siddiqui AN, Khan MA, Akhtar M, Najmi AK.
PMID: 32746478
Drug Res (Stuttg). 2020 Sep;70(9):429-436. doi: 10.1055/a-1195-1945. Epub 2020 Aug 03.

There has been an escalation in the number, diversity, and complexity of medical devices. Regulation of these devices has also advanced due to the requirement of better regulatory perspective induced due to elevation in the number of adverse events...

Cite
Hoda F, Verma R, Arshad M, et al. Materiovigilance: Concept, Structure and Emerging Perspective for Patient's Safety in India. Drug Res (Stuttg). 2020;70(9):429-436doi: 10.1055/a-1195-1945.
Hoda, F., Verma, R., Arshad, M., Siddiqui, A. N., Khan, M. A., Akhtar, M., & Najmi, A. K. (2020). Materiovigilance: Concept, Structure and Emerging Perspective for Patient's Safety in India. Drug research, 70(9), 429-436. https://doi.org/10.1055/a-1195-1945
Hoda, Farazul, et al. "Materiovigilance: Concept, Structure and Emerging Perspective for Patient's Safety in India." Drug research vol. 70,9 (2020): 429-436. doi: https://doi.org/10.1055/a-1195-1945
Hoda F, Verma R, Arshad M, Siddiqui AN, Khan MA, Akhtar M, Najmi AK. Materiovigilance: Concept, Structure and Emerging Perspective for Patient's Safety in India. Drug Res (Stuttg). 2020 Sep;70(9):429-436. doi: 10.1055/a-1195-1945. Epub 2020 Aug 03. PMID: 32746478.
Copy Download .nbib Format: NLM
[Can we talk about the existence of "hazardous medical devices"?].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Achau Muñoz R, Gaspar Carreño M, Ponce Sillas A, Márquez Peiró JF, Agún González JJ, Santos Sánchez JC.
PMID: 28683714
Farm Hosp. 2017 Jul 01;41(4):571-572. doi: 10.7399/fh.2017.41.4.10794.

No abstract available.

Cite
Achau Muñoz R, Gaspar Carreño M, Ponce Sillas A, et al. ¿Podemos hablar de la existencia de “productos sanitarios peligrosos”? [Can we talk about the existence of "hazardous medical devices"?]. Farm Hosp. 2017;41(4):571-572doi: 10.7399/fh.2017.41.4.10794.
Achau Muñoz, R., Gaspar Carreño, M., Ponce Sillas, A., Márquez Peiró, J. F., Agún González, J. J., & Santos Sánchez, J. C. (2017). ¿Podemos hablar de la existencia de “productos sanitarios peligrosos”? [Can we talk about the existence of "hazardous medical devices"?]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 41(4), 571-572. https://doi.org/10.7399/fh.2017.41.4.10794
Achau Muñoz, Rubén, et al. "¿Podemos hablar de la existencia de “productos sanitarios peligrosos”?" [Can we talk about the existence of "hazardous medical devices"?]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria vol. 41,4 (2017): 571-572. doi: https://doi.org/10.7399/fh.2017.41.4.10794
Achau Muñoz R, Gaspar Carreño M, Ponce Sillas A, Márquez Peiró JF, Agún González JJ, Santos Sánchez JC. ¿Podemos hablar de la existencia de “productos sanitarios peligrosos”? [Can we talk about the existence of "hazardous medical devices"?]. Farm Hosp. 2017 Jul 01;41(4):571-572. doi: 10.7399/fh.2017.41.4.10794. Spanish. PMID: 28683714.
Copy Download .nbib Format: NLM
[Benefit Assessment for Examination and Treatment Methods with Medical Devices of High Hisk: Trade-off between Patient Benefit, Evidence and Access].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))

Mühlbacher AC, Juhnke C.
PMID: 28753706
Gesundheitswesen. 2018 Mar;80:S80-S87. doi: 10.1055/s-0043-112742. Epub 2017 Jul 28.

The lately inured § 137 h SGB V aims to assess the benefit of new examination and treatment methods with medical devices of class IIb and III. In the future, the decision on the reimbursement eligibility will be marked...

Cite
Mühlbacher AC, Juhnke C. Nutzenbewertung für Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen: Die Abwägung von Patientennutzen, Evidenz und Zugang. [Benefit Assessment for Examination and Treatment Methods with Medical Devices of High Hisk: Trade-off between Patient Benefit, Evidence and Access]. Gesundheitswesen. 2017;80:S80-S87doi: 10.1055/s-0043-112742.
Mühlbacher, A. C., & Juhnke, C. (2018). Nutzenbewertung für Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen: Die Abwägung von Patientennutzen, Evidenz und Zugang. [Benefit Assessment for Examination and Treatment Methods with Medical Devices of High Hisk: Trade-off between Patient Benefit, Evidence and Access]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 80S80-S87. https://doi.org/10.1055/s-0043-112742
Mühlbacher, Axel C, and Juhnke, Christin. "Nutzenbewertung für Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen: Die Abwägung von Patientennutzen, Evidenz und Zugang." [Benefit Assessment for Examination and Treatment Methods with Medical Devices of High Hisk: Trade-off between Patient Benefit, Evidence and Access]. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) vol. 80 (2018): S80-S87. doi: https://doi.org/10.1055/s-0043-112742
Mühlbacher AC, Juhnke C. Nutzenbewertung für Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen: Die Abwägung von Patientennutzen, Evidenz und Zugang. [Benefit Assessment for Examination and Treatment Methods with Medical Devices of High Hisk: Trade-off between Patient Benefit, Evidence and Access]. Gesundheitswesen. 2018 Mar;80:S80-S87. doi: 10.1055/s-0043-112742. Epub 2017 Jul 28. German. PMID: 28753706.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries